Heart Failure-Related Cardiogenic Shock is a distinct entity needing a unique treatment pathway

💥Pleased to share our piece on management strategies for HF-CS @JACCJournals #JACCHF

@NavinKapur4 @vbluml @BiykemB @JumeanMarwan @NirUrielMD @MGuglin

📎 sciencedirect.com/science/articl… Highlights:
✅ How to Phenotype HF-CS
✅ Benefits of early PAC
✅ Nomenclature of HF-CS w/ SCAI-CSWG classification
✅ Endpoints to follow in response to therapy
✅ Inotrope choice, Hemodynamic Targets, choosing an MCS strategy